Retinopathy News and Research

RSS

Norrin treatment prevents vision loss in diabetic rats

Over 100 million people in the U.S. are affected by diabetic retinopathy, a complication of diabetes that affects the eyes.

30 Oct 2026

Taking a GLP-1 drug? Here's what the safety evidence really shows

A review on GLP-1 receptor agonists highlights risks like pancreatitis and thyroid cancer, emphasizing individual patient risk over general safety concerns.

26 Oct 2026

A study of 62.5 million people reveals what broad ethnic labels miss about rare diseases

Researchers analyzing health records from 62.5 million people in England found that the prevalence of 406 rare diseases varied substantially between ethnic communities, with important differences concealed by broad ethnic classifications. Recorded COVID-19 infections were also more common among people with the studied rare diseases (32.8% versus 29.0%), although differences in age, disease composition, and testing practices may have influenced these findings.

19 Oct 2026

Smartphone retinal imaging could expand global eye care screening

Smartphones could play an important role in the early detection of eye diseases, including in settings where specialized ophthalmic infrastructure is limited.

30 Sep 2026

Eye scans detect signs of atrial fibrillation years before diagnosis

People with atrial fibrillation have signs of the condition in the retinas of their eyes that can be detected as early as four years before diagnosis, finds a new study led by University College London (UCL) and Moorfields researchers.

14 Sep 2026

Gestational diabetes history linked to earlier development of type 2 diabetes

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows that, in women that develop type 2 diabetes (T2D), those who had gestational diabetes (GD) when pregnant are developing T2D on average almost 13 years earlier than those who did not.

3 Sep 2026

Type 2 diabetes mechanisms differ significantly based on patient BMI

Research published today in Diabetologia by Amsterdam UMC and the University of Ghana reveals that type 2 diabetes manifests in two fundamentally different ways depending on a patient's body mass index (BMI).

24 Aug 2026

Two early-life findings stood out in children who later screened positive for autism risk

Children born very preterm were more likely than term-born children to screen positive for autism risk at age 5 using the Social Communication Questionnaire. Among very preterm children, cerebellar abnormalities at term-equivalent age and moderate-to-severe histologic chorioamnionitis were independently associated with higher autism screening risk, alongside male sex and higher social risk.

13 Aug 2026

Intertwined cellular processes reshape understanding of diabetes

A deeper understanding of how key cellular processes interact is reshaping perspectives on diabetes and its wide-ranging complications.

5 Aug 2026

Cortisone eye drops may reduce blindness in extremely premature babies

Researchers at the University of Gothenburg and Sahlgrenska University Hospital have conducted the first randomized clinical trial in the world to test cortisone eye drops to slow the progression of serious eye disease in extremely premature babies.

3 Aug 2026

Spring clock change increases retinal vascular disease risk, study finds

For the first time, Northwestern Medicine scientists have detailed how the semiannual clock changes impact a person's risk of developing retinal vascular disease, a group of disorders that affect blood vessels in the retina and can lead to vision loss.

20 Jul 2026

Duke engineers grow retinal blood vessel cells from pluripotent stem cells

Biomedical engineers at Duke University have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel cells critical to retinal health for the first time.

30 Jun 2026

Study links cardiovascular risk factors to visual impairment in Latinos

In the U.S., Hispanic/Latino populations are disproportionately at risk for eye diseases like glaucoma and diabetic retinopathy, or vision loss tied to diabetes.

29 Jun 2026

New eye imaging technology captures clearer details of retina

Modern OCT devices can look inside the eye without a scalpel - but they do not always capture everything that matters. Some critical information is simply lost, blurred by scattered photons.

24 Jun 2026

Natural molecule erucamide helps slow progressive retinal degeneration

Many conditions that cause vision loss share a common feature: the gradual breakdown of the retina, the light-sensing tissue at the back of the eye.

22 Jun 2026

Doctors find unexpected regional differences in retinopathy of prematurity in Norway

It's a mystery. The eye disease known as retinopathy of prematurity (ROP) can make infants permanently blind if they are not treated. But there are big differences between how often Norwegian hospitals actually provide this treatment.

16 Jun 2026

AI screening tool increases diabetic eye exam referrals for African Americans

In a study exploring how an AI-assisted diagnostic tool shaped care for underserved populations at multiple community-based primary care sites, investigators at the Wilmer Eye Institute, Johns Hopkins Medicine found that African American patients with diabetes were more likely to receive a diabetic eye exam referral if screened by an AI tool.

9 Jun 2026